NCT04847635View on ClinicalTrials.gov

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Macular Degeneration, SenileLaser Burn of RetinaMacular Degeneration IntermediateMacular Degeneration, Dry
Interventions
DEVICE

Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan)

The subthreshold laser treatment will be performed using subthreshold laser Pascal Synthesis 577 on a customized macular area.

DEVICE

Pascal Synthesis 577 sham (Topcon Corporation, Tokyo, Japan)

The laser treatment will be performed without any power (only the light beam) using subthreshold laser Pascal Synthesis 577 on a customized macular area.

Trial Locations (3)

20134

RECRUITING

Giuseppe Querques, Milan

Unknown

RECRUITING

Massimo Nicolò, Genova

RECRUITING

Mariacristina Parravano, Rome

All Listed Sponsors
collaborator

Fondazione G.B. Bietti, IRCCS

OTHER

collaborator

University of Genova

OTHER

collaborator

University of Rome Tor Vergata

OTHER

lead

Ospedale San Raffaele

OTHER